Lipids and atherosclerosis: clinical management of hypercholesterolaemia

Expert Opinion on Pharmacotherapy
J P Chin-Dusting, J A Shaw

Abstract

Hypercholesterolaemia is a major risk factor for the development of atherosclerosis which, in turn, underlies most ischaemic heart disease (IHD). This review deals briefly with the pathophysiology of lipids in humans and follows with a discussion of current lipid-lowering therapies. In those patients with a history of myocardial infarction (MI) or unstable angina, appropriate lipid-lowering therapy has been convincingly shown to reduce not only cardiac events but also overall mortality. The advent of the HMG CoA reductase inhibitors in the late 1980s has had a revolutionary impact in the clinical management of hypercholesterolaemia, not only because of their efficacy but especially because they are well-tolerated. The use of other treatments such as the fibrates and bile acid resins are also discussed. Given the successful use of the statins, it is felt that an emergence of a different class of LDL-cholesterol lowering compound is unlikely in the near future and rather that compounds which can increase HDL-cholesterol while lowering LDL will be of greater impact. There may also be a shifting trend towards such naturally occurring compounds as plant stanols and phytoestrogens.

References

Apr 30, 1987·The New England Journal of Medicine·G A ColditzC H Hennekens
Dec 1, 1986·American Journal of Epidemiology·A KeysM H Keys
Jan 1, 1971·Annals of Internal Medicine·W B KannelP M McNamara
Jan 1, 1981·The New England Journal of Medicine·C D PetersonW F Keane
Dec 1, 1993·European Journal of Clinical Investigation·T HeinemannK von Bergmann
Jul 1, 1993·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·H A LehrK Messmer
Feb 1, 1993·The Journal of Pediatrics·M BeckerK Von Bergmann
Aug 15, 1996·The New England Journal of Medicine·F GrodsteinC H Hennekens
Apr 3, 1999·JAMA : the Journal of the American Medical Association·P B GorelickD C Rhew
Oct 28, 1999·Cardiovascular Research·A M Dart, J P Chin-Dusting
Aug 3, 2000·The New England Journal of Medicine·H D WhiteA M Tonkin
Aug 24, 2000·The New England Journal of Medicine·D M HerringtonD Waters

❮ Previous
Next ❯

Citations

Oct 12, 2007·Expert Opinion on Pharmacotherapy·Vasilios G AthyrosAsterios Karagiannis
Sep 11, 2019·Journal of Clinical Medicine·Armita Mahdavi GorabiAmirhossein Sahebkar
Jun 8, 2017·Frontiers in Cardiovascular Medicine·Feifei LiShi-You Chen
Jun 28, 2018·Cellular and Molecular Life Sciences : CMLS·Ting ChenQingbo Xu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.